Not provided
| ID | Type | Description | Link |
|---|---|---|---|
| LIPO-102-CL-09 |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
LIPO-102 is under evaluation for treatment of abdominal adiposity
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| LIPO-102 High | Experimental |
| |
| LIPO-102, Low | Experimental |
| |
| LIPO-102; Placebo | Placebo Comparator |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| LIPO-102 | Drug | LIPO-102 High dose |
| |
| LIPO-102 Low |
| Measure | Description | Time Frame |
|---|---|---|
| Safety | physical exam, ECG, vital signs, clinical assessment is injection site, clinical laboratory tests, and adverse events | 8 weeks treatment and 1 week follow up |
| Change in abdominal circumference | abdominal circumference | 8 weeks |
| Measure | Description | Time Frame |
|---|---|---|
| photographic assessment | abdominal circumference and volume reduction assessment | 8 weeks |
| Abdominal subcutaneous adiposity questionnaire | Patient reported outcome |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| San Diego | California | United States | ||||
Not provided
Not provided
Not provided
Not provided
Not provided
| Drug |
LIPO-102 Low dose |
|
| LIPO-102, Placebo | Drug | Placebo |
|
| 8 weeks |
| Patient and clinician photo numeric scale | patient and physician reports of change | 8 weeks |
| Patient global assessment of severity scale | patient reports of change in severity | 8 weeks |
| New York |
| New York |
| United States |
| ID | Term |
|---|---|
| D001835 | Body Weight |
| ID | Term |
|---|---|
| D012816 | Signs and Symptoms |
| D013568 | Pathological Conditions, Signs and Symptoms |
Not provided
Not provided